Biohaven Ltd.
15.00USD
+0.2800 (+1.90%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.21▲ | $-0.57 | 0 | 3 |
| Next quarter | $-0.46▲ | $-0.49 | 1 | 2 |
| Current year | $-1.97▲ | $-2.4 | 0 | 3 |
| Next year | $-1.94▲ | $-1.95 | 2 | 2 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.61 | $-0.78 | -0.17 (-27.6%) |
| 2026-03-31 | $-0.76 | $-0.69 | +0.07 (+9.7%) |
| 2025-12-31 | $-0.96 | $-0.9 | +0.06 (+5.8%) |
| 2025-09-30 | $-1.54 | $-1.47 | +0.07 (+4.8%) |
82 ratings from 18 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| RBC Capital | Downgraded from Outperform | Sector Perform | $23 $19 | Sep 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $18 $19 | Aug 12, 2026 |
| RBC Capital | Maintained | Outperform | $22 $23 | Aug 11, 2026 |
| B of A Securities | Downgraded from Neutral | Underperform | $12 $11 | Jun 29, 2026 |
| HC Wainwright & Co. | Reiterated | Neutral | $10 | May 26, 2026 |
| Morgan Stanley | Maintained | Overweight | $21 $18 | May 13, 2026 |
| RBC Capital | Maintained | Outperform | $23 $22 | May 5, 2026 |
| Citigroup | Maintained | Buy | $14 $17 | Apr 2, 2026 |
| TD Cowen | Maintained | Buy | $15 $30 | Mar 11, 2026 |
| HC Wainwright & Co. | Maintained | Neutral | $11 $10 | Mar 4, 2026 |
| RBC Capital | Maintained | Outperform | $22 $23 | Mar 3, 2026 |
| RBC Capital | Upgraded from Sector Perform | Outperform | $9 $22 | Jan 21, 2026 |
| Morgan Stanley | Maintained | Overweight | $26 $21 | Jan 6, 2026 |
| HC Wainwright & Co. | Reiterated | Neutral | $11 | Dec 26, 2025 |
| HC Wainwright & Co. | Downgraded from Buy | Neutral | $30 $11 | Dec 3, 2025 |
| UBS | Downgraded from Buy | Neutral | $26 $11 | Nov 26, 2025 |
| JP Morgan | Maintained | Overweight | $47 $15 | Nov 20, 2025 |
| Morgan Stanley | Maintained | Overweight | $54 $26 | Nov 18, 2025 |
| BTIG | Reiterated | Buy | $16 | Nov 18, 2025 |
| Citigroup | Maintained | Buy | $28 $14 | Nov 13, 2025 |
| Bernstein | Downgraded from Outperform | Market Perform | $34 $9 | Nov 6, 2025 |
| RBC Capital | Maintained | Sector Perform | $19 $9 | Nov 6, 2025 |
| BTIG | Maintained | Buy | $33 $16 | Nov 6, 2025 |
| William Blair | Downgraded from Outperform | Market Perform | — | Nov 5, 2025 |
| TD Cowen | Maintained | Buy | $50 $15 | Nov 5, 2025 |
21 filings from 8 insiders · 0 buy / 0 sell over 6m
Officers and directors of BHVN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| MEHTA KISHANDirector | Gift | 17.3k | — | — | Mar 17, 2026 |
| BUTEN MATTHEWChief Financial Officer | Other | 4.3k | — | — | Jan 5, 2026 |
| CLARK GEORGE C.Officer | Other | 2.5k | — | — | Jan 5, 2026 |
| CAR BRUCEOfficer | Other | 4.8k | — | — | Jan 5, 2026 |
| CORIC VLADIMIRChief Executive Officer | Other | 14.3k | — | — | Jan 5, 2026 |
| GENTILE KIMBERLY AOfficer | Other | 3.8k | — | — | Jan 5, 2026 |
| CLARK GEORGE C.Officer | Buyindirect | 17.0k | $8.52 | $145k | Nov 17, 2025 |
| CORIC VLADIMIRChief Executive Officer | Buyindirect | 666.7k | $7.50 | $5.00M | Nov 13, 2025 |
| BAILEY GREGORY HUGHDirector | Buy | 400.0k | $7.50 | $3.00M | Nov 13, 2025 |
| CHILDS JOHN WDirector | Buyindirect | 3.33M | $7.50 | $25.00M | Nov 13, 2025 |
| CHILDS JOHN WDirector | Buyindirect | 29.3k | $30.43 | $892k | Mar 4, 2025 |
| CHILDS JOHN WDirector | Buyindirect | 32.7k | $30.39 | $996k | Mar 4, 2025 |
| BUTEN MATTHEWChief Financial Officer | Other | 4.3k | — | — | Jan 3, 2025 |
| CLARK GEORGE C.Officer | Other | 2.5k | — | — | Jan 3, 2025 |
| CAR BRUCEOfficer | Other | 4.8k | — | — | Jan 3, 2025 |
| CORIC VLADIMIRChief Executive Officer | Other | 14.3k | — | — | Jan 3, 2025 |
| GENTILE KIMBERLY AOfficer | Other | 3.8k | — | — | Jan 3, 2025 |
| CHILDS JOHN WDirector | Buyindirect | 29.0k | $35.94 | $1.04M | Dec 30, 2024 |
| CORIC VLADIMIRChief Executive Officer | Buyindirect | 21.1k | $47.50 | $1000k | Oct 2, 2024 |
| CHILDS JOHN WDirector | Buyindirect | 21.1k | $47.50 | $1000k | Oct 2, 2024 |
No analyst notes on BHVN yet.
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 9 | 3 | 0 | 1 | Buy2.19 |
| 1 mo ago | 4 | 9 | 2 | 0 | 1 | Buy2.06 |
| 2 mo ago | 4 | 9 | 3 | 0 | 1 | Buy2.12 |
| 3 mo ago | 4 | 10 | 4 | 0 | 1 | Buy2.16 |